eBay Inc. (0R3D)
London Stock Exchange · UK · prices in USD · close of 28 Oct 2026
Key indicators
| Last close | USD 116.63 |
|---|---|
| 52-week range | 78.42 – 124.56 |
| Return, 1 month / 3 months | +8.0% / −0.4% |
| Return, 1 year / 3 years | +16.5% / +215.2% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -20.1% |
| Average daily value traded | 0.50M USD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
eBay Inc. runs online marketplaces that connect buyers and sellers of goods, ranging from collectibles and electronics to clothing and household items. Individual sellers and small businesses list products on its platforms, and buyers browse and purchase them through auctions or fixed-price listings. The company also provides payment and shipping support services to facilitate transactions. eBay is based in San Jose, California, and serves customers in many countries around the world.
The shares are listed on the London Stock Exchange in UK under the code 0R3D, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
eBay Inc. (0R3D) trades on the London Stock Exchange in UK. It last closed at USD 116.63 on 28 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,377 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.5% and over the last three months it fell 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -4.9% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.4% | ||
| 6-month return | 15.4% | ||
| 12-month return, skipping the last month | 7.9% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.1% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.50M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | +8.0% |
| 3 months | −0.4% |
| 6 months | +15.4% |
| 1 year | +16.5% |
| 3 years | +215.2% |
| 5 years | +73.4% |
Signals
| 50-day / 200-day average | 107.83 / 102.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Nov 2025 | USD 0.2900 |
| 28 Aug 2025 | USD 0.2900 |
| 29 May 2025 | USD 0.2900 |
| 14 Mar 2025 | USD 0.2900 |
| 28 Nov 2024 | USD 0.2700 |
| 30 Aug 2024 | USD 0.2700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.